XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2
SHARE-BASED COMPENSATION
 6 Months Ended
Jun. 26, 2022
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation SHARE-BASED COMPENSATION
Stock Options

For the thirteen week periods ended June 26, 2022 and June 27, 2021, the Company recognized $0.1 million of compensation expense from continuing operations related to stock options. For the twenty-six week periods ended June 26, 2022 and June 27, 2021, the Company recognized $0.3 million and $0.2 million, respectively, of compensation expense from continuing operations related to stock options. Unamortized share-based compensation expense from continuing operations as of June 26, 2022 amounted to $0.6 million which is expected to be recognized over the next 1.9 years. As of June 26, 2022, a total of 1.0 million shares remain available for issuance under 2013 Plan.
 
A summary of stock option activity is presented as follows:
 Number of
Shares		Weighted Average Exercise Price Per ShareWeighted Average Remaining Contractual LifeTotal Intrinsic Value of Awards
(in thousands)
Options outstanding at December 26, 2021695,329 $16.91 6.7$665 
Exercised(650)$9.72 
Forfeited / Canceled(32,000)$17.43 
Options outstanding at June 26, 2022662,679 $16.89 6.1$703 
Options exercisable at December 26, 2021475,765 $17.62 5.9$452 
Options exercisable at June 26, 2022463,765 $17.78 5.3$475 
 Number of
Shares		Weighted Average Grant Date Fair Value
Nonvested outstanding at December 26, 2021219,564 $12.73 
Nonvested outstanding at June 26, 2022198,914 $12.78 

For the twenty-six week period ended June 26, 2022, the Company did not issue shares under a cashless exercise. For the twenty-six week period ended June 27, 2021, the Company issued 213 shares of common stock upon the cashless exercise of 600 stock options.

Restricted Stock

For the thirteen week periods ended June 26, 2022 and June 27, 2021, the Company recognized $0.1 million of compensation expense related to restricted stock awards. For the twenty-six week periods ended June 26, 2022 and June 27, 2021, the Company recognized $0.2 million of compensation expense related to restricted stock awards. Unamortized share-based compensation expense as of June 26, 2022 amounted to $0.6 million which is expected to be recognized over the next 2.1 years.
A summary of restricted stock activity is presented as follows:

 Number of
Shares		Weighted Average Grant Date Fair Value
Restricted stock outstanding at December 26, 202160,844 $11.91 
Issued19,434 $13.51 
Vested(10,046)$13.39 
Restricted stock outstanding at June 26, 202270,232 $11.81 
Nonvested outstanding at December 26, 202160,844 $11.91 
Nonvested outstanding at June 26, 202270,232 $11.81 

The intrinsic value in the tables above is the amount by which the market value of the underlying stock exceeded the exercise price of outstanding options or warrants, before applicable income taxes and represents the amount holders would have realized if all in-the-money options or warrants had been exercised on the last business day of the period indicated.

2020 Employee Stock Purchase Plan (“2020 ESPP”)

In November 2020, the Company's shareholders approved the 2020 ESPP. Under the 2020 ESPP, eligible team members of the Company may elect for payroll deductions to purchase shares on each purchase date during an offering period. A total of 250,000 shares of common stock of BGSF, Inc. were initially reserved for issuance pursuant to the 2020 ESPP. For the twenty-six week period ended June 26, 2022, the Company issued 36,912 shares of common stock under the 2020 ESPP.